These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38277849)

  • 1. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States.
    Connor GS; Labiner DM; Schabert VF; Weingarten M; Wade CT; Stern S; Becker DA
    Epilepsy Behav; 2024 Mar; 152():109649. PubMed ID: 38277849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
    Stern S; Weingarten M; Mandapati S; Ferrari L; Wade CT
    Epilepsy Res; 2023 Nov; 197():107207. PubMed ID: 37741165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
    Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
    CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database.
    Chen S; Fukasawa T; Ikeda A; Takeuchi M; Shimotake A; Yoshida S; Kawakami K
    Heliyon; 2023 Apr; 9(4):e15017. PubMed ID: 37064469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
    Aboumatar S; Ferrari L; Stern S; Wade CT; Weingarten M; Connor GS; Rosenfeld WE
    Epilepsy Res; 2024 Feb; 200():107306. PubMed ID: 38340681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of antiseizure medication use and cost in the United States of America 2006-2021.
    Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM
    Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Youngerman BE; Choi H; Burke JF
    Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.
    Bolin K; Patric B; Tomson T
    Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
    Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
    Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force.
    Tomson T; Battino D; Bromley R; Kochen S; Meador KJ; Pennell PB; Thomas SV
    Epileptic Disord; 2022 Dec; 24(6):1020-1032. PubMed ID: 36193017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
    Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
    Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
    Privitera M; Richy FF; Schabert VF
    Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.
    Hoeltzenbein M; Slimi S; Fietz AK; Stegherr R; Onken M; Beyersmann J; Dathe K; Schaefer C
    Seizure; 2023 Apr; 107():107-113. PubMed ID: 37003184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
    Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
    Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Leppien EE; Doughty BJ; Hurd KL; Strong KN; Piper BJ; McCall KL
    Clin Drug Investig; 2023 Jun; 43(6):393-399. PubMed ID: 37184612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.
    Terman SW; Lin CC; Kerr WT; DeLott LB; Callaghan BC; Burke JF
    Neurology; 2022 Aug; 99(8):e751-e761. PubMed ID: 35705496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world antiseizure medication treatment outcomes in drug-resistant focal epilepsy patients.
    Hatoum HT; Arcona S; Mao J; Walton S
    Epilepsia Open; 2023 Dec; 8(4):1556-1565. PubMed ID: 37842746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy of anti-seizure medications using matched cohorts on a large insurance claims database.
    Kan-Tor Y; Ness L; Szlak L; Benninger F; Ravid S; Chorev M; Rosen-Zvi M; Shimoni Y; Fisher RS
    Epilepsy Res; 2024 Mar; 201():107313. PubMed ID: 38417192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.